Table of contents
Volume 83, Issue 4
Published online 25 July 2000 (421-559)
Regular Articles
Performance and standards for the process of head and neck cancer care: South and West audit of head and neck cancer 1996–1997 (SWAHN I) FREE
M A Birchall, D Bailey and A Lennon on behalf of the South and West Regional Cancer Organisation Tumour Panel for Head and Neck Cancer
Br J Cancer 83: 421-425; doi:10.1054/bjoc.2000.1302
Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT) FREE
J S de Bono, J Paul, A Simpson, A Anthoney, D Kirk, M Underwood, J Graham and S B Kaye
Br J Cancer 83: 426-430; doi:10.1054/bjoc.2000.1290
Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure FREE
G Freyer, P Rougier, R Bugat, J-P Droz, M Marty, H Bleiberg, D Mignard, L Awad, P Herait, S Culine, V Trillet-Lenoir and the CPT-11 F205, F220, F221 and V222 study groups
Br J Cancer 83: 431-437; doi:10.1054/bjoc.2000.1303
A phase II trial of paclitaxel and epirubicin in advanced breast cancer FREE
D Rischin, J Smith, M Millward, C Lewis, M Boyer, G Richardson, G Toner, H Gurney and J McKendrick
Br J Cancer 83: 438-442; doi:10.1054/bjoc.2000.1306
Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer FREE
M S Simms, D P Scholfield, E Jacobs, D Michaeli, P Broome, J E Humphreys and M C Bishop
Br J Cancer 83: 443-446; doi:10.1054/bjoc.2000.1315
Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer – a randomized trial with quality of life as the primary outcome FREE
H Anderson, P Hopwood, R J Stephens, N Thatcher, B Cottier, M Nicholson, R Milroy, T S Maughan, S J Falk, M G Bond, P A Burt, C K Connolly, M B McIllmurray, J Carmichael and on behalf of the UK NSCLC Gemcitabine Group
Br J Cancer 83: 447-453; doi:10.1054/bjoc.2000.1307
Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma FREE
M Raderer, F Vorbeck, M Formanek, C Österreicher, J Valencak, M Penz, G Kornek, G Hamilton, B Dragosics and A Chott
Br J Cancer 83: 454-457; doi:10.1054/bjoc.2000.1308
A phase II study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer FREE
C Kollmannsberger, D Quietzsch, C Haag, T Lingenfelser, M Schroeder, J T Hartmann, W Baronius, V Hempel, M Clemens, L Kanz and C Bokemeyer
Br J Cancer 83: 458-462; doi:10.1054/bjoc.2000.1295
The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel FREE
A Vazina, J Baniel, Y Yaacobi, A Shtriker, D Engelstein, I Leibovitz, M Zehavi, A A Sidi, Y Ramon, T Tischler, P M Livne and E Friedman
Br J Cancer 83: 463-466; doi:10.1054/bjoc.2000.1249
Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts FREE
E C Burt, L A James, M J Greaves, J M Birch, J M Boyle and J M Varley
Br J Cancer 83: 467-472; doi:10.1054/bjoc.2000.1292
Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer FREE
P M Schneider, H W Praeuer, O Stoeltzing, J Boehm, J Manning, R Metzger, U Fink, S Wegerer, A H Hoelscher and J A Roth
Br J Cancer 83: 473-479; doi:10.1054/bjoc.2000.1287
Tumour necrosis factor- 
and transforming growth factor- 
are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization FREE
L Boldrini, A Calcinai, E Samaritani, F Pistolesi, A Mussi, M Lucchi, C A Angeletti, F Basolo and G Fontanini
Br J Cancer 83: 480-486; doi:10.1054/bjoc.2000.1345
Pathology characteristics that optimize outcome prediction of a breast screening trial FREE
T J Anderson, F E Alexander, J Lamb, A Smith and A P M Forrest
Br J Cancer 83: 487-492; doi:10.1054/bjoc.2000.1286
Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours FREE
A A Jungbluth, E Stockert, Y-T Chen, D Kolb, K Iversen, K Coplan, B Williamson, N Altorki, K J Busam and L J Old
Br J Cancer 83: 493-497; doi:10.1054/bjoc.2000.1291
Expression of topoisomerase III in normal and neoplastic tissues determined by immunohistochemistry using
a novel monoclonal antibody FREE
A J Lodge, J J Anderson, S W Ng, F Fenwick, M Steward, B Haugk, C H W Horne and B Angus
Br J Cancer 83: 498-505; doi:10.1054/bjoc.2000.1293
Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins FREE
G Pirtskhalaishvili, G V Shurin, C Esche, Q Cai, R R Salup, S N Bykovskaia, M T Lotze and M R Shurin
Br J Cancer 83: 506-513; doi:10.1054/bjoc.2000.1289
Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiation FREE
S Vaganay-Juéry, C Muller, E Marangoni, B Abdulkarim, E Deutsch, P Lambin, P Calsou, F Eschwege, B Salles, M Joiner and J Bourhis
Br J Cancer 83: 514-518; doi:10.1054/bjoc.2000.1258
Down-regulation of TGF- 1 production restores immunogenicity in prostate cancer cells FREE
E Matthews, T Yang, L Janulis, S Goodwin, S D Kundu, W J Karpus and C Lee
Br J Cancer 83: 519-525; doi:10.1054/bjoc.2000.1257
Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats FREE
N Carbó, J López-Soriano, P Costelli, S Busquets, B Alvarez, F M Baccino, L S Quinn, F J López-Soriano and J M Argilés
Br J Cancer 83: 526-531; doi:10.1054/bjoc.2000.1299
Interferon- 2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism FREE
F Romerio, A Riva and D Zella
Br J Cancer 83: 532-538; doi:10.1054/bjoc.2000.1263
Porphyrin biosynthesis in human Barrett's oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid FREE
P Hinnen, F W M de Rooij, E M Terlouw, A Edixhoven, H van Dekken, R van Hillegersberg, H W Tilanus, J H P Wilson and P D Siersema
Br J Cancer 83: 539-543; doi:10.1054/bjoc.2000.1300
Proteolysis of microtubule associated protein 2 and sensitivity of pancreatic tumours to docetaxel FREE
R Veitia, S David, P Barbier, M Vantard, P Gounon, M C Bissery and A Fellous
Br J Cancer 83: 544-549; doi:10.1054/bjoc.2000.1294
Oestrogen inactivation in the colon: analysis of the expression and regulation of 17 -hydroxysteroid
dehydrogenase isozymes in normal colon and colonic cancer FREE
M A English, S V Hughes, K F Kane, M J S Langman, P M Stewart and M Hewison
Br J Cancer 83: 550-558; doi:10.1054/bjoc.2000.1324
Calendar
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
